Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Investigate common budgeting blockers that prevent savings and identify actionable changes. This intro guides you toward steady, growing savings.
27,247 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Clayton launches the TRU Mini Home Collection, sub-900 square feet, built for narrow lots and smaller parcels. The mo...
Onity Group completes the rebranding of PHH Mortgage to Onity Mortgage, extending the Onity brand across its mortgage...
Morgan Stanley boosted its price target on Planet Labs to $35, citing rising defense and intelligence demand and a ro...
A former hedge-fund executive warns that investors dangerously complacent about Iran conflict risks as oil volatility...
A new CBO forecast warns that social security’s trust fund could be empty by 2032, triggering automatic cuts that wou...
Celanese (CE) stands at an inflection point as 2026 begins. This article breaks down the potential drivers behind cel...
Barclays slashed Coinbase’s price target to $107 following aQ1 2026 revenue miss, highlighting a tug-of-war between c...
AMD’s latest earnings call highlights a rapid AI-led growth wave and a massive server CPU opportunity. Here are the f...
Mizuho raises Dell's price target to $300 on expected durable demand from agentic AI servers, while UBS nudges valuat...
Doximity is due to report Q4 results after the close, with analysts keyed to FY2027 guidance and margin trajectory as...
Strategy unveils a private repurchase of roughly $1.5 billion in convertible notes, funded by cash, ATM proceeds, and...